Nitrous Acid

Nitrous Acid

SCHEMBL1656758

O.O.O.O=NO.[MgH2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Nitrous Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitrous Acid SCHEMBL9614569 1.00 CA1 (0.75)
Nitrous Acid SCHEMBL221694 0.94
Nitrous Acid SCHEMBL27722546 0.94
Nitrous Acid SCHEMBL27450854 0.94
Nitrous Acid SCHEMBL249421 0.94
Nitrous Acid SCHEMBL2781743 0.94
Nitrous Acid SCHEMBL15302796 0.94 CA1 (0.86)
Nitrous Acid SCHEMBL1965248 0.88 CA1 (0.75)
Nitrous Acid SCHEMBL4376222 0.88
Nitrous Acid SCHEMBL21830602 0.88 CA1 (0.75)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220273702-A1 HYDROGEN SULFIDE AND NITRIC OXIDE THERAPY FOR COVID-19 INFECTION BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2022-09-01 US claimed
US-12139402-B2 Pharmaceutical formulations of nitrite and uses thereof BOARD OF SUPERVISORS OF LOUISIANSA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2024-11-12 US disclosed
US-20220273702-A1 HYDROGEN SULFIDE AND NITRIC OXIDE THERAPY FOR COVID-19 INFECTION BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2022-09-01 US disclosed
US-20220169508-A1 PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2022-06-02 US disclosed
US-11247902-B2 Pharmaceutical formulations of nitrite and uses thereof BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2022-02-15 US disclosed
US-11116731-B2 Hydrogen sulfide and/or nitrite in the treatment and prevention of atrial fibrillation Brd. of Sup. of LSU and A &M College (US) 2021-09-14 US disclosed
US-10864207-B2 Method of treating endothelial dysfunction Celagenex Research (India) Pvt. Ltd. (IN) 2020-12-15 US disclosed
US-20200297756-A1 PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2020-09-24 US disclosed
US-20200222383-A1 POTENT SYNERGISTIC COMPOSITIONS OF VASOACTIVE MEDIATORS ENHANCERS FOR IMPROVING VASCULAR ENDOTHELIAL FUNCTION Celagenex Research (India) Pvt. Ltd. (IN) 2020-07-16 US disclosed
WO-2020141546-A1 SYNERGISTIC NUTRITIONAL COMPOSITIONS FOR PAIN MANAGEMENT Celagenex Research (India) Pvt. Ltd. (IN) 2020-07-09 WO disclosed
US-20140112983-A1 NITRITE COMPOSITIONS AND USES THEREOF THERAVASC INC. (US) 2014-04-24 US disclosed
US-20130209584-A1 PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF THERAVASC INC. (US) 2013-08-15 US disclosed
WO-2012142413-A2 NITRITE COMPOSITIONS AND USES THEREOF THERAVASC INC. (US) 2012-10-18 WO disclosed
WO-2012135623-A1 USE OF NITRITES FOR THE TREATMENT OF CEREBRAL AMYLOID ANGIOPATHY, AGE ASSOCIATED DEMENTIA, AND COGNITIVE DECLINE THERAVASC INC. (US) 2012-10-04 WO disclosed
CN-102686111-A Pharmaceutical formulations of nitrite and uses thereof THERAVASC LLC 2012-09-19 CN disclosed
EP-2488035-A1 PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF Theravasc Inc. (US) 2012-08-22 EP disclosed
WO-2011047161-A1 PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF TheraVasc, LLC (US) 2011-04-21 WO disclosed
US-20110086069-A1 PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF TheraVasc, LLC (US) 2011-04-14 US disclosed
US-4174228-A SPRAYABLE FIREPROOFING MATERIAL PPG INDUSTRIES, INC. (US) 1979-11-13 US disclosed
US-4174229-A SPRAYABLE FIREPROOFING MATERIAL PPG INDUSTRIES, INC. (US) 1979-11-13 US disclosed